Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Ear Hear. 2019 Nov-Dec;40(6):1261–1266. doi: 10.1097/AUD.0000000000000731

Table 1.

Estimated trade-off of sensitivity and specificity

CEDRA score Sensitivity (%) Specificity (%) # of false positives per 100 patients # of missed TEDs per 100 patients
X 100 0 95 0
2 98 39 58 0
4 90 72 27 1
8 54 95 5 2
12 20 100 0 4

Data based on the initial “training” sample from Kleindienst et al. (2017) and an assumed TED prevalence of 5% for illustrative purposes. The first row represents every patient receiving a medical evaluation, and assumes the physician would catch every targeted ear disease (TED). Subsequent rows show different CEDRA cut-off scores and the estimated outcomes.